References
Arcamone F., Cassinelli G., Fantini G., Grein A., Orezzi P., Pol C., Spalla C.: Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic fromS. peuceticus var.caesius.Biotechnol. Bioeng. 11, 1101 (1969).
Arcamone F., Cassinelli G., Franceschi G., Orezzi P., Mondelli R.: The total absolute configuration of daunomycin.Tetrahedron Letters 3353 (1968).
Arcamone F., Cassinelli G., Orezzi P., Franceschi G., Mondelli R.: Daunomycin. II. The structure and stereochemistry of daunosamine.J. Amer. Chem. Soc. 86, 5335 (1964b).
Arcamone F., Cassinelli G., Penco S., Tognali L.: Antibiotische Substanzen und Verfahren zu ihrer Herstellung. Offen. 1.923.885 (1970).
Arcamone F., Di Marco A.,Gaetani M., Scotti T.: Isolation and antitumor activity of an antibiotic from streptomyces.Giorn. Microbiol. 9, 83 (1961).
Arcamohe F., Franceschi G., Orezzi P., Cassinelli G., Barbieri W., Mondelli R.: Daunomycin. I. The structure of daunomycinon.J. Amer. Chem. Soc. 86, 5334 (1964a).
Arcamone F., Franceschi G., Orezzi P., Penco S.: The structure of daunomycin.Tetrahedron Letters 3349 (1968).
Arcamone F., Franceschi G., Penco S., Selva A.: Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic.Tetrahedron Letters 1007 (1969).
Arnone A., Fronza G., Mondelli R., Vigerani A.: 13C NMR analysis of the antitumor antibiotics daunorubicin and adriamycin.Tetrahedron Letters 3349 (1976).
Asheshov L. N., Gordon J. J.: Rutilantin: an antibiotic substance with antiphage activity.Biochem. J. 81, 101 (1961).
Bachur N. R.: Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions.J. Pharm. Exptl. Therap. 177, 573 (1971).
Bachur N. R.: Adriamycin (NSC-123, 117) pharmacology.Cancer Chemotherapy Rep. (Part. 3).6, 153 (1975).
Bachur N. R., Gee M.: Daunorubicinol metabolism by rat tissue preparations.J. Pharm. Exptl. Therap. 177, 657 (1971).
BÉRDY J., Zsadányi J., Halász M., Horváth I., Magyar K.: Cytotetrin, a new antitumor antibiotic.J. Antibiot. 24, 210 (1971).
Berg H., Eckardt K.: Zur Interaktion von Anthracyclinen und Anthracyclinonen mit DNS.Z. Naturforsch. 25b, 362 (1970).
Bergy M. E., Reusser F.: A new antibacterial agent (UC-20, 661) isolated from a streptomycete strain.Experientia 23, 254 (1967).
Bhuyan B. K., Kelly R. B., Smith R. M.: Antibiotic nogalamycin. U.S. Patent 3,183,157, Feb. 1 (1963).
Bhuyan B. K., Smith C. G.: Differential interaction of nogalamycin with DNA of varying base composition.Proc. Nat. Acad. Sci. U.S.A. 54, 566 (1965).
Biedermann E., Bräuniger H.: Untersuchungen zur Isolierung und Konstitutionaufklärung der Rhodomycin-Antibiotika des Streptomyces-Stammes JA 8467.Pharmazie 27, 782 (1972).
Blinov N. O., Khokhlov A. S., in Bumazhnaya khromatografiya antibiotikov. Izd. Nauka, Moskva,148, 1970.
Blinov N. O., Yakubov G. Z., Artamonova O. I., Khokhlova Yu. M.: Isolation of antibiotics of the mycetin-violarin group by paper chromatography. (In Russian)Antibiotiki 7, 1063 (1962).
Bogdanova N. P., Kovaleva L. A., in Materialy 2-oy Konf. Molodykh Uchen. Leningr. Inst. Antibiotikov, Leningrad,13, Sb. 1964 (Chem. Abstr. 63, 1654).
Bradler G., Eckardt K., Fügner R.: Zur Charakterisierung der Streptomyces-Stammes JA 3043 und Gewinnung von Galirubin und Galirubinonen.Z. Allg. Mikrobiol. 6, 361 (1966).
Brahic M., Tamalet J.: Effects of adriamycin D and rubidomycin on sindbis virus replication.Compt. Rend. Soc. Biol. 162, 1557 (1969).
Brazhnikova M. G., Konstantinova N. V., Mezentsev A. S., Pomazkova V. A.: Studies on chemical properties of rubomycin B. (In Russian)Antibiotiki 13, 781 (1965).
Brazhnikova M. G., Zbarskii V. B., Ponomarenko V. I., Potapova N. P.: Physical and chemical characteristics and structure of carminomycin, a new antitumor antibiotic.J. Antibiot. 27, 254 (1974).
Brazhnikova M. G., Zbarskii V. B., Potapova N. P., Sheynker Yu. N., Vlasova T. F., Rozynov B. V.: Structure of aglycone of carminomycin, an antitumour antibiotic. (In Russian)Antibiotiki 18, 1054 (1973).
Brockmann H.: Anthracyclinone und Anthracycline (Rhodomycinone, Pyrromycinone und ihre Glykoside).Fortschr. Chem. Org. Naturstoffe 21, 122 (1963).
Brockmann H., Bauer K., Borchers I.: Rhodomycin, ein rotes Antibiotikum.Chem. Ber. 84, 700 (1951).
Brockmann H., Boldt P.: ε-Iso-rhodomycinon.Chem. Ber. 94, 2174 (1961).
Brockmann H., Borchers I.: Rhodomycin.Chem. Ber. 86, 261 (1953).
Brockmann H., Brockmann H., Jr., Niemeyer J.: Die absolute Konfiguration der Anthracyclinone.Tetrahedron Letters 4719 (1968).
Brockmann H., Greve H.: Zur Kenntnis der β-Rhodomycine.Tetrahedron Letters 831 (1975).
Brockmann H., Lenk W.: Pyrromycin.Chem. Ber. 92, 1904 (1959a).
Brockmann H., Lenck W.: Pyrromycinone.Chem. Ber. 92, 1880 (1959b).
Brockmann H., Niemeyer J.: Rhodomycine, XII: Antibiotica aus Actinomyceten. LVI. Konfiguration und Konformation von α-Rhodomycinon, β-Rhodomycinon und β-Iso-rhodomycinon.Chem. Ber. 100, 3578 (1967).
Brockmann H., Niemeyer J.: Rhodomycine. XIII. Antibiotica aus Actinomyceten, LVII. α2-Rhodomycinon, α-Citromycinon, γ-Citromycinon.Chem. Ber. 101, 1341 (1968).
Brockmann H., Niemeyer J., Brockmann H., Jr.,Budzikiewicz H.: α-Rhodomycinon, β-Rhodomycinon, 10-Desoxy-γ-rhodomycinon.Chem. Ber. 98, 3785 (1965a).
Brockmann H., Niemeyr J., Rode W.: β-Iso-rhodomycinon.Chem. Ber. 98, 3145 (1965b).
Brockmann H., Patt P.: Iso-rhodomycin A, ein neues Antibioticum aus Streptomyces purpurascens.Chem. Ber. 88, 1455 (1955).
Brockmann H., Scheffer B., Stein C.: Isolierung neuer Rhodomycine.Tetrahedron Letters 3699 (1973).
Brockmann H., Spohler E.: Zur Konstitution des Rhodomycin A.Naturwissenschaften 48, 716 (1961).
Brockmann H., Waehneldt T.: Eine neue Gruppe von Rhodomycinen.Naturwissenschaften 48, 717 (1961).
Brockmann H., Waehneldt T., Niemeyer J.: Konstitution und Konfiguration von β-Rhodomycin II und β -Iso-rhodomycin II.Tetrahedron Letters 415 (1969).
Brockmann H., Jr.: Thesis, Göttingen (1963).
Brockmann H., Jr.,Budzikiewicz H., Djerassi C., Brockmann H., Niemeyer J.: Das massenspektroskopische Fragmentierungsverhalten der Anthracyclinone.Chem. Ber. 98, 1260 (1965).
Brockmann H., Jr.,Legrand M.: Zirkulardichroismus von Pyrromycinonen, Rhodomycinonen und Isorhodomycinonen.Tetrahedron 19, 395 (1963).
Brodasky T. F., Reusser F.: Steffimycin B, a new member of the steffimycin family: isolation and characterization.J. Antibiot. 27, 809 (1974).
Bromer W. W., Hoehn M. M., McGuire J. M.: Antibiotic A-195 and process for the preparation thereof. U.S. Patent 3,467,751, Aug. 2, 1965.
Budzikiewicz H., Djerassi C., Williams D. H.: In Structure elucidation of natural products by mass spectrometry. Holden-Day, Inc., San Francisco, London, Amsterdam, vol. 2, s. 241 (1964).
Bullock F. J., Bruni R. J., Asbell M. A.: Identification of new metabolites of daunomycin and adriamycin.J. Pharm. Exp. Ther. 182, 70 (1972).
Casazza A. M., Gambarucci C., Silvestrini R.: Effects of daunomycin and adriamycin on the marine sarcoma virus (Moloney)in vitro. Europ.J. Clin. Biol. Res. 17, 622 (1972).
Decio de Andrade Lyra F., Goncalves de Lima O., Sidney de Barros Coelho J., Fernandes de Albuquerque M. M., Maciel G. M., Linz de Olivira L., Navarro Maciel M. C.: Ciclamioina and ciclacidina, two new colored antibiotics, produced byStreplomyces capoamus.Anais Acad. Brasil. Cienc. 36, 323 (1964).
DI Marco A.,Arcamone F.: DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.Arzneimittel-Forsch. 25, 368 (1975).
DI Marco A.,Arcamone F., Zunino F.: Daunomycin (daunorubicin) and adriamycin and structural analogues: Biological activity and mechanism of action, in Antibiotics vol. III,Mechanism of Action of Antimicrobial and Antitumor Agents. Corcoran J. W., and Hahn F. E. (eds.), Springer-Verlag Berlin p. 101 (1975).
DI Marco A.,Boretti G., Rusconi A.: Transformazione metabolica della daunomycina da parte di estratti di tessuti.Il Farmaco 7, 535 (1967).
DI Marco A.,Rusconi A.: Action mechanism and metabolite transformation of daunomycin.Gann Monographies 2, 23 (1967).
DI Marco A.,Terni M., Silvestrini R., Scarpinato B., Biagioli E., Antonelli A.: Effect of daunomycin onHerpes virus hominis in human cells.Giorn. Microbiol. 16, 26 (1968).
Dudnik Yu. V., Ostanina L. N., Kozmyan L. I., Gauze G. F.: Mechanism of carminomycin action. (In Russian)Antibiotiki 19, 514 (1974).
Eckardt K.: Zur Identifizierung einer Reihe von Anthracyclinonpigmenten ausStreptomyces galilaeus Stamm JA 3043 (Galirubine und Galirubinone).Chem. Ber. 100, 2661 (1967).
Eckardt K., Tresselt D., Tax J.: Isolierung und Konstitution von Aklavinon-I und Aklavinon-II, zwei neuen Anthracyclinonen aus Fermentationsansätzen vonStreptomyces galilaeus.Tetrahedron 30, 3787 (1974).
Eckardt K., Tresselt D., Tax J., Jancke H.: Isolierung und Struktur von zwei neuen Anthracyklinone aus Kulturen vonStreptomyces galilaeus.Z. Chem. 14, 57 (1974).
Ettlinger L., Gäumann E., Hütter R., Keller-Schierlein W., Kradolfer E., Neipp L., Prelog V., Reusser P., Zähner H.: Cinerubine.Chem. Ber. 92, 1867 (1959).
Fedorova G. B.: Studies on carbohydrate composition of rubomycin B. (In Russian)Antibiotiki 15, 403 (1970).
Fernandes de Albuquerque M. M., Decio de Andrade Lyra F., Gonçalves de Lima O., Linz de Oliveira L., Sidney de Barros Coelho J., Medeiros Maciel G., Cavalcanti M. S. B.: Miniatomycins, antibiotics produced byStreptomyces 4363—IAUFP.Rev. Inst. Antib., Univ. Recife,6, 35 (1966).
Fleck W., Strauss D., Koch W., Prauser H.: Violamycin, a new red-pigment antibiotic.Allg. Mikrobiol. 14, 551 (1974).
Fleck W., Strauss D., Schönfeld C., Jungstand W., Seeber C., Prausbr H.: Screening, fermentation, isolation and characterization of trypanomycin, a new antibiotic.Antimicrobial Agents &Chemother.1, 385 (1972).
Furer N. M., Fochina I. P., Artamonova O. I., Bamsina T. I.: The antiviral effect of antibiotics produced by cultures ofActinomyces violaceus. (In Russian)Antibiotiki 4, 30 (1959).
Gadó I., Boromissza E., Horváth I.: The effect of daunomycin on phage induction.J. Antibiot. 22, 574 (1969).
Gauze G. F., Brazhnikova M. G., Shorin V. A.: A new antitumor antibiotic, carminomycin (NSC —180024).Cancer Chemother. Reports (Part 1) 58, 255 (1974).
Gauze G. F., Maksimova T. S., Olkhovateva O. L., Terekhova L. F., Kochetkova G. V., Ilchenko G. B.: Production of beromycin byActinomyces griseoruber var.beromycini. (In Russian)Antibiotiki 17, 8 (1972).
Germanova K. I., Goncharskaya T. Ja., Saveliyeva A. M.: Antiviral properties of vaccinocidin. (In Russian)Antibiotiki 9, 997 (1964).
Goldberg L. E., Filifposyants S. T., Stepanova E. S.: Studies on toxicity and pharmacological properties of berromycin, a new antitumour antibiotic. (In Russian)Antibiotiki 17, 616 (1972).
Gonçalves de Lima O., Decio de Andrade Lyra F., Fernandes de Albuquerque M. M., Medeiros Maciel G., Sidney de Barros Coelho J.: Antibiotio and antitumor activity of retamycin obtained fromStreptomyces olidensis. (In Port.).Rev. Inst. Antib., Univ. Fed. Pernambuco, Recife 9, 27 (1969).
Gordon J. J., Jackman L. M., Ollis W. D., Sutherland I. O.: Aklavinone.Tetrahedron Letters 28 (1960).
Hegyi J. R., Gerber N. N.: N1-pyrromycinone a new tetracene-quinone (anthracyclinone) fromStreptomyces sp. I-8.Tetrahedron Letters 1587 (1968).
Heyns K., Kiessling G., Müller D.: The mass spectra of derivatives of 2-amino-2-deoxy-d-galactose.Carbohyd, Res. 4, 452 (1967).
Heyns K., Müller D.: The mass spectra of permethylated N-acetyl-aminosugars.Tetrahedron 21, 3151 (1965).
Higashide E., Hasegawa T., Shibata M.: Lateriomycins A and B, new antitumor and antibacterial antibiotics produced byStreptomyces griseoruber, strain No. 71070.J. Antibiot. 22, 409 (1969).
Hori M., Takeuchi T., Kando S., Hamada M., Okazaki T., Okami Y., Umezawa H.: Requinomycin, an inhibitor of R-factor transfer: Isolation, characterization and properties.J. Antibiot. 25, 393 (1972).
Chandra P., Zunino F., Götz A., Gericke D., Thorbeck R., Di Marco A.: Specific inhibition of DNA-polymerase from RNA tumor viruses by some new daunomycin derivatives.FEBS Lett. 21, 264 (1972).
Inouye S.: Mass spectra of N-salicylidene aminosugars.Chem. Pharm. Bull. (Japan)20, 2320 (1972).
Iwamoto R. H., Lim P., Bhacca N. S.: The structure of daunomycin.Tetrahedron Letters 3891 (1968).
Jaffe N., Traggis D. C., Das L.: Daunorubicin (NSC-83142) in advanced childhood leukemia.Cancar Chemother.58, 661 (1974).
Keller-Schiererin W., Richle W.: Structure of cinerubine A.Antimicrobial Agents & Chemother.68 (1970).
Kochetkov N. K., Chizhov O. S.: Mass spectrometry of carbohydrate derivatives.Adv. Carbohyd. Chem. 21, 39 (1966).
Krassilnikov N. A., Koreniako A. J.: The bactericidal substance of theActinomycetes. (In Russian.)Mikrobiologiya 8, 673 (1939).
Lin W. Ch., Cullen W. P., Rao K. V.: Mitocromin: An antibiotic with antitumor activity.J. Antibiot. 22, 608 (1969).
Mallams A. K.:d-Rhodosamin, a new dimethylaminosugar.J. Chem. Soc. 1369 (1973).
Mitscher L. A., McCrae W., Andres W. W., Lowery J. A., Bohonos N.: Ruticulomycins, new anthracycline antibiotics.J. Pharm. Sci. 53, 1139 (1964).
Oki T., Matsuzawa Y., Yoshimoto A., Numata K., Kitamura I., Hori S., Takamatsu A., Umezawa H., Ishizuka M., Naganawa H., Suda H., Hamada M., Takeuchi T.: New antitumor antibiotics, aclacinomycins A and B.J. Antibiot. 28, 830 (1975).
Ollis W. D., Sutherland J. O., Codner R. C., Gordon J. J., Miller D. A.: The incorporation of propionate in the biosynthesis of ε-pyrromycinone (rutilantinone).Proc. Chem. Soc. (London) 347 (1960).
Paranosenkova V. I., Karpov V. L.: The study of rubomycin biosynthesis.Bioorg. Khim. 1, 1755 (1976).
Penco S.: New glycosides of daunomycinone.Chim. Ind. (Milan) 56, 908 (1968).
Perevodchikova N. I., Gorbunova V. A., Lichinitser M. R., Borisov V. I., Alekseyev N. A., Vygovskaya Ya. I.: First stage of clinical trials of carminomycin, an antitumour antibiotic. (In Russian)Antibiotiki 20, 853 (1975).
Pigram W. J., Fuller W., Hamilton L. D.: Stereochemistry of intercalation: Interaction of daunomycin with DNA.Nature New Biol. 235, 17 (1972).
Poroshina G. I.: An antibiotic, isolated from actinomycete 135/1, having a high bacteriocidal activity toward lactic bacteria. (In Russian)Mikrobiol. Zh. Akad. Nauk Ukr. RSR,26, 25 (1964) (Chem. Abstr. 62, 10877).
Reed R. I., Reid W. K.: Electron impact and molecular dissociation —XIII. The pyrromycinones and rhodomycinones.Tetrahedron 19, 1817 (1963).
Rhône-Poulenc: Japan 8, 800 (1965) May 7.
Rhône-Poulenc S. A.: Nouvel antibiotique et sa préparation. Belg. Pat. No. 632391 (18. 2. 1962). Franc. Pat. 1,5837521 P.V. No. 142.443 (1968).
Richle W., Winkler E. K., Hawley D. M., Dobler M., Keller-Schierlein W.: Die Struktur des Cinerubins B.Helv. Chim. Acta 55, 48 (1972).
San Filippo A., Mazzoleni E.: Aktivita antifagica dell’ antibiotico daunomycina.Ciorn. Microbiol. 12, 83 (1964).
Shoji J., Kozuki S., Nishimura H., Mayama M., Motokawa K., Tanaka Y., Otsuka H.: Isolation of an antibiotic S-583-B, related to rhodomycin A and B.J. Antibiot. 21, 643 (1968).
Soloveva N. N., Taig M. M., Trakhtenberg D. M., Birlova L. V., Sorokina N. A.: Characteristics of the organism producing an antiviral antibiotic vaccinocidin, its recovery and properties. (In Russian)Antibiotiki 9, 596 (1964).
Strauss D., Fleck W., Prauser H.: Verfahren zur Herstellung eines cancerostatisch, virostatisch, baktericid und proticid wirksamen Antibiotikums sowie seines Aglykons (Dihydro-Leukaemomycin C). DDR —Pat. 107948 (1974).
Strauss D., Fleck W., Prauser H., Schönfeld Ch., Jungstand W.: Trypanomycin —a new antibiotic with antiprotozoal activity. In Advances in Antimicrobial and Antineoplastic Chemotherapy. Proc. VIIth Intern. Congress of Chemotherapy,Hejzlar M., Semonský M., Masák S. (eds.). Prague, p. 413 (1971).
Strelitz F., Flon H., Weiss U., Asheshov I. N.: Aklavin, an antibiotic substance with antiphage activity.J. Bacteriol. 72, 90 (1956).
Tax J., Sedmera P., Vokoun J., Eckardt K., Komersová I., Vaněk Z.: ε1-Pyrromycinone, a new anthracyclinone fromStreptomyces galilaeus JA 3043.Coll. Czech. Chem. Commun. 38, 2661 (1973).
Trakhtenberg D. M., Birlova L. V., Baykina V. M.: Isolation and properties of antivirus antibiotie violarin B. (In Russian)Antibiotiki 6, 603 (1961).
Tresselt D., Eckardt K., Tax J.: Zur Konfiguration und Konformation von Aklavinon-I und Aklavinon-II, zwei neuen Anthraeyklinonen aus Kulturansätzen vonStreptomyces galilaeus.Tetrahedron 31, 613 (1975).
Tulinsky A.: The structure of isoquinocycline A.: An X-ray crystallographic determination.J. Amer. Chem. Soc. 86, 5368 (1968).
Upjohn Co., Neth. 6,503,333, Mar. 1965.
Vigevani A., Gioia B., Cassinelli G.: Mass spectrometry of some N-acyldaunosamine derivatives.Carbohyd. Res. 32, 321 (1974).
Weil M., Glidewell O. J. et al.: Daunorubicin in the therapy of acute granulocytic leukemia.Cancer Research 33, 921 (1973).
WILEY P. F., MacKellar F. A., Caron E. L., Kelly R. B.: Isolation, characterization and degradation of nogalamycin.Tetrahedron Letters 663 (1968).
Yakubov G. Z., Blinov N. O., Sergeyeva L. N., Artamonova O. I., Khokhlov A. S.: Mycetins B1, B2 and C, new antibiotics of rhodomycin group. (In Russian)Antibiotiki 10, 771 (1965).
Yesair D. W., Asbell M. A., Bruni R., Bullock F. J., Schwarzbach E.: Fharmacokinetics and metabolism of adriamycin and daunomycin. Internat. Symp. on Adriamycin, Milano (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaněk, Z., Tax, J., Komersová, I. et al. Anthracyclines. Folia Microbiol 22, 139–159 (1977). https://doi.org/10.1007/BF02881640
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02881640